| Financial Year |
March 31 2023 |
| Monetary Funds |
3,402,300,605.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
838,118,910.23 |
| Advances to Suppliers |
90,227,683.26 |
| Other Receivables |
751,307,833.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
36,735,336.78 |
| Dividend Receivable |
-- |
| Inventories |
1,123,645,632.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
110,000,000.00 |
| Other Current Assets |
126,760,682.18 |
| Total Current Assets |
6,547,743,933.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
86,943,122.12 |
| Investment Properties |
85,506,891.21 |
| Fixed Assetes |
346,639,837.82 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
130,455,159.92 |
| R&D expenses |
-- |
| Goodwill |
610,838,930.87 |
| Long-Term Deferred and Prepaid Expenses |
13,522,328.98 |
| Deferred Income Tax Assets |
172,043,604.24 |
| Other Non-Current Assets |
1,973,337,047.45 |
| Sub-Total of Non-Current Assets |
4,961,775,277.62 |
| Total Assets |
11,509,519,210.96 |
| Short-Term Loans |
768,280,524.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
103,266,485.45 |
| Accounts Payable |
655,363,783.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
94,552,126.23 |
| Taxes Payable |
106,345,657.71 |
| Interest Payable |
-- |
| Dividend Payable |
5,768,234.95 |
| Other payables |
3,241,676,612.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,633,665.21 |
| Other Current Liabilities |
11,801,985.05 |
| Sub-Total of Current Liabilities |
5,309,309,103.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
51,478,255.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
133,464,476.62 |
| Total Liabilities |
5,442,773,580.21 |
| Paid-In Capital(Or Share Stock) |
1,032,062,937.00 |
| Capital Surplus |
1,749,461,962.52 |
| Surplus Reserve |
314,708,085.76 |
| LESS:Treasury Stock |
281,152,433.68 |
| Undistributed Profits |
3,056,130,950.55 |
| Minority Stockholder's Interest |
177,261,978.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,889,483,652.63 |
| Owner's Equity（Stockholder's Equity） |
6,066,745,630.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,509,519,210.96 |
